NiKang Therapeutics’ US$200 Million Equity Financing

Sidley Austin LLP advised the lead investors on the deal.HBM Healthcare Investments, Cormorant Asset Management, and Octagon Capital Advisors, with participation from a syndicate of other leading…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now